Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Medtronic
Julphar
Federal Trade Commission
Daiichi Sankyo
Baxter

Generated: July 15, 2019

DrugPatentWatch Database Preview

Patent: 9,809,588

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,809,588
Title:GLS1 inhibitors for treating disease
Abstract: Disclosed herein are compounds and compositions useful in the treatment of GLS1 mediated diseases, such as cancer, having the structure of Formula I: ##STR00001## Methods of inhibition GLS1 activity in a human or animal subject are also provided.
Inventor(s): Di Francesco; Maria Emilia (Houston, TX), Jones; Philip (Houston, TX), Heffernan; Timothy (Sugar Land, TX), Hamilton; Matthew M. (Missouri City, TX), Kang; Zhijun (Sugar Land, TX), Soth; Michael J. (Sugar Land, TX), Burke; Jason P. (Houston, TX), Le; Kang (Sugar Land, TX), Carroll; Christopher Lawrence (Houston, TX), Palmer; Wylie S. (Houston, TX), Lewis; Richard (Houston, TX), McAfoos; Timothy (Houston, TX), Czako; Barbara (Houston, TX), Liu; Gang (Sugar Land, TX), Theroff; Jay (Manvel, TX), Herrera; Zachary (Houston, TX), Yau; Anne (Houston, TX)
Assignee: Board of Regents, The University of Texas System (Austin, TX)
Application Number:14/791,186
Patent Claims:see list of patent claims

Details for Patent 9,809,588

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up Board of Regents, The University of Texas System (Austin, TX) ➤ Sign Up RX Orphan search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Sign Up Board of Regents, The University of Texas System (Austin, TX) ➤ Sign Up RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20 ➤ Sign Up Board of Regents, The University of Texas System (Austin, TX) ➤ Sign Up RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 003 1991-02-20 ➤ Sign Up Board of Regents, The University of Texas System (Austin, TX) ➤ Sign Up RX search
Amgen NEUPOGEN filgrastim VIAL 103353 002 1991-02-20 ➤ Sign Up Board of Regents, The University of Texas System (Austin, TX) ➤ Sign Up RX search
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20 ➤ Sign Up Board of Regents, The University of Texas System (Austin, TX) ➤ Sign Up RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ➤ Sign Up Board of Regents, The University of Texas System (Austin, TX) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 9,809,588

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Daiichi Sankyo
Mallinckrodt
Baxter
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.